NANOSTEM is a Marie Skłodowska-Curie Innovative Training Network (ITN) funded by the European Commission through the Horizon 2020 Research and Innovation programme. The project started on June 2018 and will last for 4 years. The network is coordinated by Prof Marina Resmini at QMUL and comprises 9 beneficiary partners and 5 partner organisations from the academic and the industrial sectors, from 7 countries (United Kingdom, Sweden, Portugal, France, Germany, Austria and Italy).
The NANOSTEM project addresses brain drug delivery to target specifically neurogenic niches from a holistic approach. The multidisciplinary expertise of the consortium will enable tackling advanced NP formulations, new drugs, advanced screening of NP formulations in a human BBB model, and in vivo testing of the formulations in the neural stem cells (NSC). This provides a unique training platform that links chemistry, polymer science and nanotechnology with neuroscience, stem cell biology and clinical neurology. The 14 ESRs trained by the network will become a new generation of nanomedicine experts able to work and communicate across disciplines.
Also on Facebook, Instagram and Twitter:
https://www.facebook.com/nanostem.msca.1
https://www.instagram.com/nanostem_msca/
https://twitter.com/nanostemMSCA
Company Details
- Founded
- -
- Address
- Mile End Road, School Of Biological And Chemical Sciences,united Kingdom
- Industry
- Research
- Website
- https://www.nanostem.qmul.ac.uk/
- HQ
- London, England
- Competitors
- Controlled Release Society, Epithelial Cell Biology in ENT Research Group (EpiCENTR), European Partnership for the Assessment of Risks from Chemicals (PARC), POP's Lab at SLU, GliaGenesis Ltd., Mesenbio, Oxford Cryotechnology, Sistemic Ltd, American Institute for Medical and Biological Engineering, Cellinta Limited.
Nanostemitn Questions
Nanostemitn's website is https://www.nanostem.qmul.ac.uk/
Nanostemitn's LinkedIn profile is https://uk.linkedin.com/company/nanostemitn
Nanostemitn's industry is
Research
Nanostemitn's top competitors are
Controlled Release Society,
Epithelial Cell Biology In Ent Research Group (Epicentr),
European Partnership For The Assessment Of Risks From Chemicals (Parc),
Pop's Lab At Slu,
Gliagenesis Ltd.,
Mesenbio,
Oxford Cryotechnology,
Sistemic Ltd,
American Institute For Medical And Biological Engineering,
Cellinta Limited.
Nanostemitn's categories are Research
Nanostemitn's founding year is 2018
